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Abstract
The process of choosing dialysis modality for patients is complex and requires input from the expert renal team. Although
it is commonplace for nephrologists to recommend dialysis modalities to patients, this might not always lead to the patient
receiving treatment which they regard as most suitable. Nephrologists should consider whether it is appropriate for pre-
dialysis education to be directive, or whether the choice between treatment options should be led by the patient.
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How do patients choose between treatments for end-stage kid-
ney disease? The process and method of dialysis modality
selection by patients is complex, nuanced and subject to multi-
ple influences. How do patients then receive the treatment they
have chosen? Even after modality selection, the process of then
delivering this treatment to patients can be challenging and
renal services frequently fail to start patients’ renal replace-
ment therapy using their stated chosen treatments [1, 2].
Whatever the process, Registry data tell us that dialysis
modality choice alters between geographical areas and over
time, and all analyses show a reduction in uptake of home
therapies over the last two or three decades [3, 4].
Although nearly all nephrologists and patients would regard
transplantation as the superior modality of renal replacement
therapy, the relative advantages of dialysis modalities over
each other continue to be debated [5–7]. There are some strong
advocates for home therapies, and reasons cited for such a
point of view often contain a mixture of individual clinical indi-
cations and utilitarian principles of maximal usage of limited
resources [7, 8]. On the whole, however, guidelines broadly rec-
ommend that selection between these options should be a
shared decision-making process between health care professio-
nal and an informed patient [9]. Shared decision-making takes
into account the best clinical evidence available, as well as the
patient’s values and preferences. It needs patients and profes-
sionals to understand what is important to the other person
when choosing a treatment [10].
For example, the European Best Practice Advisory Board [11]
recommend that patients ‘. . . should receive well-balanced
information about the different RRT modalities by means of a
structured education programme’, thereby ‘. . . [making] sure
that all patients can select the modality that is most suitable for
them’. Although such statements are inarguable, the devil is in
the detail, and defining what constitutes ‘well-balanced
information’ and ‘modality that is most suitable’ is extremely
challenging. Even though it is well established that how options
are framed or presented affects the choices people make [12],
recent reports indicate significant variation in the delivery and
content of pre-dialysis education programmes [13].
In this issue of CKJ, De Maar et al. [14] describe ‘GUIDE, a
structured pre-dialysis program that increases the use of home
dialysis’. In the article, the authors describe a retrospective
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analysis of outcomes in patients with advanced chronic kidney
disease subject to a novel structured pre-dialysis education pro-
gramme, termed ‘GUIDE’. Over a 12-month period following
introduction of ‘GUIDE’, the uptake of home dialysis modalities
among patients with advanced chronic kidney disease who
progress on to dialysis was higher than in historical controls
from the same centre.
For those nephrologists wishing to increase uptake of home
therapies, adopting a process resembling ‘GUIDE’ would appear
to be a method of doing so.
At the heart of ‘GUIDE’ are six things—first, the programme
has a home-focused approach in which, if transplantation can-
not take place in a timely fashion, home dialysis is advised
above centre-based treatment by a team who aspire to increase
uptake of home therapies; secondly, patients are visited at
home by a case manager, who reviews the patients circumstan-
ces and completes a questionnaire indicating their view of the
patient’s suitability for home dialysis; questionnaires are also
completed by the patient and their nephrologist, the latter indi-
cating the nephrologist’s treatment preference; thirdly, there is
a multidisciplinary meeting (MDM) (in the patient’s absence)
where the most suitable treatment for this particular patient is
chosen; fourthly, after the MDM, the patient is educated, usually
in a single session, about their dialysis options; fifthly, after a
second MDM, patient and nephrologist choose the modality,
and finally the patient is prepared for and started on dialysis.
A strength of the ‘GUIDE’ process is the transparency of the
policy, goals and actions of their programme, and further trans-
parency about how they have involved the patient in their pro-
fessional and service infrastructure. However, within this
structure the patient is educated and chooses their modality
after an MDM has determined what is most suitable for them.
Although this may reflect practice in many nephrological
centres, it is a directive process, and it should be recognized
that there may well be tensions between the view of a health
care professional (subject to service delivery frameworks/initia-
tives/other incentives) [8] and the view of the patient about
what is best for them.
Although consultant nephrologists are highly trained and
experienced practitioners, it has been demonstrated that the
views of individual practitioners about patient suitability for
dialysis vary widely. When presented with patient scenarios in
experimental conditions, nephrologists practising in the same
nephrological service vary in their assessment of suitability
from completely suitable to completely unsuitable [15]. Similar
results have been described in other similar experiments [16].
In addition, in a series of highly revealing discrete choice
experiments conducted among health care professionals,
patients and those close to them, Morton et al. showed us that
the views of patients about the trade-offs necessary to choose
dialysis modality can also be different from those looking after
them, being either professionals or loved ones [17–19].
Education can inform patients about treatment choices and
preparation for care [20], and if appropriately designed might
enable patients to make treatment choices reflecting their life-
style preferences in the context of their disease [21]. However,
patient information can also enable understanding, help with
coping or adjusting and develop self-management skills includ-
ing adherence [22]. One interpretation of the ‘GUIDE’ process
would be that it aims to increase adherence of patients to their
health care team’s favoured treatment choice, and patients who
choose not to take up a home therapy might be seen as non-
adherent. When implementing the ‘GUIDE’ process, it is inter-
esting that the MDM view of suitability for home therapy was
1.5–2 times the rate judged by the patients. The ability of a
patient to challenge the recommendation of a health care pro-
fessional is variable, but studies of a decision aid introduced to
support patient modality choice has shown that use of such
materials lead to patients being less dependent on others to
make such decisions [21]. Furthermore, such information was
also shown to make patients more likely to challenge the view
of a health care professional when it does not match their per-
sonal beliefs and values [21]. Although patients may report sat-
isfaction with their dialysis team’s care of them, they also
report valuing help to make an informed decision, rather than
being encouraged to adhere to a choice given to them [23].
Leaving aside the issues of education and modality selection
for a moment, there are also interesting results with regard to
service delivery.
It is interesting to note that even with the ‘GUIDE’ pro-
gramme in place, there was not an increased uptake of home
therapies at dialysis start compared with historical controls. In
addition, the numbers choosing a home therapy fell between
discussion and declaration of modality choice, and fell further
when patients actually started renal replacement therapy.
Furthermore about one-quarter of patients did not start with
the treatment of their choice. It appears that even in a renal
centre with a desire to promote home therapy, a patient who
has chosen home therapy may not start treatment this way but
instead commence in-centre dialysis.
The authors cite a lack of training capacity as one of the
issues underlying this problem. This is a very objective issue, and
another recent study identified similar practical barriers—includ-
ing perceived medical contraindications and lack of space—
which prevented patients starting dialysis at home even after
choosing it among the options [24]. Addressing these issues
through service design is required by all nephrologists, and
patient flow analyses may be very helpful in identifying barriers
to the practical implementation of home therapies [2]. Such flow
analysis might also identify where extra numbers of home ther-
apy patients were recruited from in programmes where this is
promoted. Reproducing the flow diagram as from the current
article may be an instructive undertaking for many renal services
[14], and similar previous initiatives have suggested this [2].
However, in both studies, other much more subjective bar-
riers to starting home dialysis were identified, even after this
modality had been chosen. These include a feeling of fear,
insufficient education or lack of confidence leading to ulti-
mately declining home therapy when recommended or failing
to start on it even having apparently chosen it [14]. These latter
reasons would appear particularly amenable to intervention by
structured pre-dialysis education; however, if patients are
reporting such problems even after structured pre-dialysis edu-
cation then the programme itself would seem to require at least
some adjustment. It is important to recognize that even appa-
rent difficulties with service delivery may at least have some of
their roots in the more complex and subtle issues raised by the
patient pre-dialysis education programme.
The important point is that the educational programme
should be one that is directed towards producing patients who
are informed and activated, to enable shared decision-making
to properly take place [25, 26]. The ingredients necessary to pro-
duce activated, informed patients have been well defined by
health psychologists and decision-scientists. Patients need to
be prompted to understand that ‘they’ have a decision to make;
‘they’ need to learn the required information without bias and
assimilate the facts with ‘their’ existing values to make ‘their’
own decision [26].
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The authors of the article presenting the ‘GUIDE’ pre-dialysis
education programme describe a directive educational pro-
gramme that can increase home therapy uptake. What is
unclear is whether it is appropriate for clinicians to guide
patients to the clinicians’ preferred treatment or if we should
allow the patients to lead the clinicians to the patients’ most
suitable treatment.
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